| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720009 Matrix protein compositions for treating infection |
| 04/13/2004 | US6719987 Sustained release of metal microbiocides |
| 04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004029025A2 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | WO2004028531A1 Preventive or remedy for bedsore |
| 04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028519A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028495A1 Hair treatment agent containing an active combination of liposomes |
| 04/08/2004 | WO2004028484A1 Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028441A2 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
| 04/08/2004 | WO2004014396A9 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004006943A3 Use of a chrysanthellum extract |
| 04/08/2004 | WO2004006937A3 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 04/08/2004 | WO2004005350A3 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/08/2004 | WO2004004680A3 Cosmetic composition for fighting against skin ageing |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000227A3 Use of thio-oxindole derivatives in treatment of skin disorders |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003031430A3 Flavonoid compounds and their pharmaceutical uses |
| 04/08/2004 | WO2002100373B1 Skin preparation |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068129 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 04/08/2004 | US20040067894 Preparation having antioxidant properties |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067246 Topical solution containing a chromane or chromene derivative |
| 04/08/2004 | US20040067245 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 04/08/2004 | US20040067243 Enhancedly-solubilized beta-hydroxy acids and higher potency skin peels formulated therefrom |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067211 Emulsion composition |
| 04/08/2004 | CA2500360A1 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499689A1 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/07/2004 | EP1405844A1 Cycloalkenone derivative |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1405633A1 Composition, particularly for cosmetics containing an aromatic aminoketone |
| 04/07/2004 | EP1405560A1 Il-18 transgenic animal |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404713A1 Novel keratinocyte growth factor-2 analogue in hair follicle |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404413A2 Dermatological formulations |
| 04/07/2004 | EP1404412A1 Treatment and composition for wound healing |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404327A2 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 04/07/2004 | EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404318A2 Compounds and methods for regulating cell differentiation |
| 04/07/2004 | EP1404315A1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones |
| 04/07/2004 | EP1404311A1 Wound treatment agent |
| 04/07/2004 | EP1404291A1 Water-free ubichinon concentrate |
| 04/07/2004 | EP1404287A2 Hair lotion stimulating hair growth |
| 04/07/2004 | EP1404268A1 Treating epidermlyosis bullosa with thymosin beta 4 |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1303267B1 Dermal for amino laevulinic acid |